Atom Investors’s Centessa Pharmaceuticals CNTA Stock Holding History

Atom Investors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-158,509	Closed	-$6.3M	–	863
2026 Q1	$6.3M	Buy	158,509 +140,162	+764%	+$3.59M	0.45%	48
2025 Q4	$459K	Buy	+18,347	New	+$465K	0.04%	396
2025 Q1	–	Sell	-17,197	Closed	-$288K	–	529
2024 Q4	$288K	Buy	+17,197	New	+$285K	0.04%	386

Atom Investors's CNTA Position: Q2 2026 in Review

Atom Investors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 158,509 shares — an estimated $6.3M sold.

Atom Investors first reported a position in CNTA in Q4 2024 and held it in 3 quarters. The position peaked at $6.3M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Atom Investors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Atom Investors sold 158,509 Centessa Pharmaceuticals shares in Q2 2026, an estimated $6.3M.
Atom Investors first reported a position in Centessa Pharmaceuticals in Q4 2024 and held it in 3 quarters.
Atom Investors's Centessa Pharmaceuticals position peaked at $6.3M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.